Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:59 AM
Study NCT ID:
NCT01059305
Status:
TERMINATED
Last Update Posted:
2017-04-04
First Post:
2010-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-28
First Submit QC Date:
None
Study First Post Date:
2010-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-16
Results First Submit QC Date:
None
Results First Post Date:
2017-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-16
Last Update Post Date:
2017-04-04
Last Update Post Date Type:
ACTUAL